Compare ARKO & OFIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ARKO | OFIX |
|---|---|---|
| Founded | 1970 | 1987 |
| Country | United States | United States |
| Employees | 9748 | N/A |
| Industry | Oil Refining/Marketing | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 608.8M | 473.3M |
| IPO Year | N/A | 1998 |
| Metric | ARKO | OFIX |
|---|---|---|
| Price | $6.10 | $12.86 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 5 |
| Target Price | $7.50 | ★ $17.25 |
| AVG Volume (30 Days) | ★ 1.1M | 228.9K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.11% | N/A |
| EPS Growth | N/A | ★ 29.39 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $822,312,000.00 |
| Revenue This Year | $12.86 | $6.10 |
| Revenue Next Year | $1.49 | $6.24 |
| P/E Ratio | $56.88 | ★ N/A |
| Revenue Growth | N/A | ★ 2.85 |
| 52 Week Low | $3.71 | $10.25 |
| 52 Week High | $6.71 | $16.99 |
| Indicator | ARKO | OFIX |
|---|---|---|
| Relative Strength Index (RSI) | 62.93 | 61.64 |
| Support Level | $5.80 | $12.33 |
| Resistance Level | $6.65 | $16.38 |
| Average True Range (ATR) | 0.25 | 0.41 |
| MACD | 0.05 | 0.19 |
| Stochastic Oscillator | 93.88 | 88.71 |
ARKO Corp owns and operates convenience stores in the United States. Some of its regional store brands include Stop, Admiral, Apple Market, BreadBox, E-Z Mart, fas mart, Li'l Cricket, and Next Door Store. Its retail store offers hot food service, beverages, cigarettes & other tobacco products, candy, salty snacks, grocery, beer, and general merchandise. ARKO operates in four segments: Retail segment, Wholesale segment, fleet fueling segment, and GPM Petroleum segment. It derives the majority of its revenue from retail and wholesale distribution of fuel.
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.